ArticleInvestigational new drugs2019

CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.

Muhammed H Rahaman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.